Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT01825798 Completed - Overweight Clinical Trials

Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)

MET
Start date: April 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether metformin is safe and effective in the treatment of weight or weight gain in young people with Autism Spectrum Disorders (ASD) who are currently taking atypical antipsychotic medication.

NCT ID: NCT01823250 Completed - Clinical trials for Substance Use Disorders

Culturally Informed Family Based Treatment of Adolescents: A Randomized Trial

CIFFTA
Start date: January 2011
Phase: Phase 2
Study type: Interventional

This Stage II randomized trial tests Culturally Informed & Flexible Family Based Treatment for Adolescents (CIFFTA) developed as part of a Stage I treatment development effort and yielding promising preliminary findings. Drug use rates are highest among Hispanic middle school youth and to date no treatments have met criteria for "Well Established" in the treatment of substance abuse in Hispanic adolescents. Further treatment for Hispanic youth and families is complicated by the fact that these families often differ from mainstream populations in culture-related values, beliefs and behaviors that can directly impact engagement, retention, and efficacy/effectiveness of drug treatment. Our efforts to develop a more powerful treatment capable of addressing these issues began with a Stage 1 study that led to the development of a multi-component treatment that includes a flexible manual that allows treatment tailoring to the unique characteristics of individual families. CIFFTA integrates innovative culturally-based, individually-based, and family-based components to: 1) reduce maladaptive family processes (e.g., poor parenting practices, family conflict) and increase family protective factors (e.g., strong parent-child attachment), 2) teach adolescents skills to effectively manage interpersonal conflicts and stressors and to increase motivation to change, 3) deliver psycho-educational and culturally congruent material (e.g., modules on immigration stressors) to youth and parents both separately and together, and 4) deliver the intervention using a flexible treatment manual that allows the clinician to tailor the treatment (e.g., by selecting the most relevant psycho-educational modules and themes) to the unique characteristics and needs of the Hispanic family. This Stage II randomized trial randomizes 220 Hispanic adolescents ages 14-17 who meet DSM-IV criteria for Substance Abuse to a 4-month treatment of either CIFFTA or Traditional Family Therapy. The study tests CIFFTA's efficacy in impacting drug use, risky sexual behavior, and other severe behavior problems, and hypothesized mechanisms of change, in a larger and more rigorous Stage II trial. Assessments occur at baseline, 4 months post baseline (end of treatment), 10 months post baseline and 16 months post baseline. Should this line of research continue to be successful, it has the potential to contribute to the field a highly innovative and efficacious treatment for Hispanic drug abusing adolescents, a better understanding of mechanisms of treatment efficacy, and also a framework for future flexible and tailored treatments that can be used to better address the unique needs of other special populations.

NCT ID: NCT01822418 Completed - Schizophrenia Clinical Trials

Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)

AGOPSYCH
Start date: January 2013
Phase: Phase 4
Study type: Interventional

Major depressive episodes (MDEs) occur frequently during the course of psychotic disorders, and several antidepressive agents have been successfully applied. The new melatonergic antidepressant agomelatine (AGO) appears promising for the treatment of MDEs in schizophrenia for several reasons. The investigators plan to test the efficacy and tolerability of AGO for antidepressive treatment in schizophrenia. For this task, the investigators plan to enrol 27 schizophrenic patients into an open, single-armed, prospective clinical trial with agomelatine.

NCT ID: NCT01822392 Completed - Conduct Disorder Clinical Trials

On-line Treatment for Conduct Problems

Start date: November 2012
Phase: N/A
Study type: Interventional

The research evaluates the use of online versions of delivering an effective psychological treatment for children clinically referred for serious oppositional, aggressive, and antisocial behavior. The goal is to develop models of delivery that reach families in need that are not being served by in-person treatment. The project has immediate implications for the treatment of children but more generally addresses several issues critical to treatments that are based on Internet, telepsychiatry, and related technologies.

NCT ID: NCT01820286 Completed - Depression Clinical Trials

Positive Psychology for Mood Disorders

PPBPAD
Start date: March 2013
Phase: N/A
Study type: Interventional

The investigators are doing this study to see if "positive psychology" can help adults with depression or bipolar disorder. Positive psychology involves exercises—short tasks—that try to increase good feelings and emotions, like optimism, happiness, personal strengths, and well-being. Positive psychology exercises might include imagining a bright future, being grateful for good events, forgiving others, and doing kind acts for others. The investigators want to see if practicing positive psychology exercises after leaving the hospital can increase feelings of hope, optimism, and positive thinking. The investigators are asking you to take part in this research study because you are in the hospital for depression or bipolar disorder. This research study will compare "positive psychology exercises" to "control condition exercises." During the study, you may take part in control condition exercises instead of positive psychology exercises.

NCT ID: NCT01818778 Completed - Impaired Cognition Clinical Trials

The Efficacy of Using Volunteers to Implement a Cognitive Stimulation Program in Two Long-Term Care Homes

VolCogStim
Start date: May 2013
Phase: N/A
Study type: Interventional

Many volunteers visiting seniors make socially-based "friendly visits". This study investigated the efficacy of volunteers making visits focused on stimulating cognition. Participants were randomly assigned to either a "friendly visit" control group or a cognitive stimulation group. Seniors receiving stimulation visits made statistically significant improvement in memory abilities.

NCT ID: NCT01818453 Completed - Clinical trials for Major Depressive Disorder

Can Genetics Predict Treatment Response to a Computerized Self-help Program for Depression?

Start date: March 2013
Phase: N/A
Study type: Interventional

The goal of this project is to determine whether genetic information can be used to predict response to an internet-based treatment of depression. Several studies now indicate that completing an internet-based treatment for depression, called Deprexis, can significantly improve symptoms of depression. However, not everyone improves. The purpose of this study is to determine whether genetic profile can predict who is likely to improve.

NCT ID: NCT01815398 Completed - Anxiety Disorders Clinical Trials

Cognitive Skills Training for Homeless Youth

Start date: July 2012
Phase: N/A
Study type: Interventional

Many young people who are homeless have cognitive deficits which impede their ability to secure and maintain employment. This study looks to see if targeting cognitive deficits can improve cognition and vocational outcome.

NCT ID: NCT01814579 Enrolling by invitation - Clinical trials for Disease (or Disorder); Gynecological

Vaginal Cuff Closure Time Using Unidirectional Barbed Suture in Robotic Hysterectomy

Start date: July 2012
Phase: N/A
Study type: Interventional

This study is designed to determine if using the V-Loc Wound Closure System expedites operative time in robotic hysterectomy.

NCT ID: NCT01814098 Completed - Clinical trials for Depressive Disorder, Major

An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms

Lexapro
Start date: July 7, 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of long term escitalopram treatment in participants with Major Depressive Disorder (MDD) with associated anxiety symptoms.